Albumin-Specific Testing Outperforms Total Protein Measurement in Detecting Kidney Disease: Study

Written By :  Dr. Kamal Kant Kohli
Published On 2025-11-17 14:45 GMT   |   Update On 2025-11-17 14:45 GMT
Advertisement

An individual patient-level meta-analysis assessed and compared the performance of urinary albumin–creatinine ratio (UACR) and urinary protein–creatinine ratio (UPCR) across chronic kidney disease (CKD)-related clinical outcomes. The analysis found that UACR was more strongly associated with development of kidney failure than UPCR, supporting the use of UACR as the preferred measure to stratify patients at risk for CKD-related outcomes. The findings are published in Annals of Internal Medicine.

Advertisement

Researchers from the Chronic Kidney Disease Prognosis Consortium (CKD-PC) studied data from 148,994 participants in cohorts of the CKD-PC who had UACR and UPCR measured on the same day. Cohorts are eligible to join the CKD-PC if they have sufficient data on kidney function and subsequent clinical outcomes.

The researchers quantified the associations of UACR and UPCR with outcomes including incident kidney failure with kidney replacement therapy, myocardial infarction, stroke, heart failure, and cardiovascular death. The researchers found consistent associations for both UACR and UPCR for CKD-related adverse clinical outcomes. However, UACR was more strongly associated than UPCR with incident kidney failure.

For patients with higher baseline UACR, lower estimated glomerular filtration rate (eGFR), diabetes, or glomerulonephritis, the comparative advantage of UACR was particularly strong. Associations with cardiovascular disease-related outcomes were similar for both UACR and UPCR, but subgroups with a higher baseline UACR saw somewhat stronger associations with UACR than with UPCR. The findings support the routine measurement of UACR to risk-stratify patients for CKD-related adverse outcomes. 

Reference: Hiddo J.L. Heerspink, Morgan E. Grams, Yingying Sang, et al. Proteinuria or Albuminuria as Markers of Kidney and Cardiovascular Disease Risk: An Individual Patient–Level Meta-analysis. Ann Intern Med. [Epub 4 November 2025]. doi:10.7326/ANNALS-25-02117

Tags:    
Article Source : Annals of Internal Medicine

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News